Lacer will launch in January an innovative probiotic that contributes to reduce the cholesterol in blood by 14%.

-the company will distribute Primacol ® exclusively on Spain

Barcelona, 2011-October the pharmaceutical division of laboratories Lacer, Lacer Farma, specialist in cardiovascular health, market starting next January an innovative probioticcapable of reducing total cholesterol in the blood by 14%. The launch is the result of the agreement reached with the biotech AB-Biotics for distribution in exclusive of probiotic AB-Life in Spain, Lacer Farma will sell under the trade name Primacol ®.

Probiotic Primacol ® formula has been created from three strains of Lactobacillus plantarum, selected from over 500 strains. Thanks to this combination of bacteria, which are usually found in the intestines of healthy people, Primacol ® favors the precipitation of bile salts, hindering resorption of cholesterol in the intestine, resulting in a greater uptake of plasma cholesterol by the liver to synthesize new bile salts. Therefore, total cholesterol in the blood, either dietary source of endogenous production, looks
decreased.

Clinical studies show by AB-Biotics in the Hospital, gate iron Madrid, volunteers aged between 18 and 65 years with a cholesterol level above 200 mg/dl, the consumption of Primacol ®, which will be available in capsules, he managed to reduce total cholesterol in the blood by 14%. This order reductions represent a decrease of more than 28% of cardiovascular risk, according to epidemiological studies and clinical trials available.

For the Director General of Lacer Farma, José Miguel Noriega, ” as specialists in cardiovascular health, we are aware that high cholesterol is one of the risk factors most important to a large part of the population. The incorporation of Primacol ® to our range of products of diagnosis, prevention and reduction of cardiovascular risk, allows us to make available to one of the most comprehensive therapeutic arsenals health professionals in this field ’ ’.

The launch of Primacol ® is part of the strategy of the company to focus on the health problems from a global perspective, patient-centred. As explained by José Miguel Noriega, ‘ ’ to pharmaceutical products to combat various cardiovascular risk factors, such as hypertension and Dyslipidemia, have recently added equipment for measuring and monitoring of blood pressure, as well as pharmaceutical care related cardiovascular risk. Now, with Primacol ®, incorporate a dietary supplement that will help to reduce cholesterol levels of everyone concerned for their health cardiovascular. ”

data of the Spanish society of physicians in primary care (SEMERGEN) established that you between 50% and 70% of Spaniards have cholesterol levels above 200 mg/dl and 20% more than 250 mg/dl. Among schoolchildren, high cholesterol levels affect already at 22%.

About LACER FARMA

LACER Pharma, the pharmaceutical division of laboratories LACER, is a leader in the domestic market in the area of cardiovascular risk, among others, and makes available to health professionals a wide range of pharmaceutical and health products and services with high added value.

LACER, with a turnover in 2010 of 155 million euros, is a Spanish company specialized in the care of human health with a global scope. Its action covers the pharmaceutical industry including the sectors of health and personal hygiene care.

On AB BIOTICS

AB-BIOTICS is a Spanish biotech company focused on research, development, protection and distribution of own and exclusive, biotechnological solutions with the Mission of improving health and well-being of people. From July 2010, AB-BIOTICS is the first biotechnology company with headquarters in Catalonia, and the second in Spain, which is listed in the Stock Exchange alternative market (aim), incorporating companies expanding segment. The company is currently developing a capital increase to boost an international expansion plan that will allow you to have direct presence in countries such as United States, United Kingdom, Germany, France, Turkey, Mexico or Brazil.